Market model and entry evaluation for a MedTech device in Europe

The client had developed an algorithm-based MedTech device for a neurological disease. The market was diverse and had no relevant comparator, meaning the client needed clarity on market conditions and a plan that covered all aspects of their launch strategy in the EU4 and UK.

We identified and assessed potential analogues and their reimbursement models, developing an EU forecast, LOC model, and comprehensive strategic launch plan. Additionally, we identified and interviewed payers and KOLs to test pricing options and reimbursement models. The client was presented with a range of strategic options for market entry, and we helped implement the initial phases so they could reach their turnover target.

The client was able to assess their options in the context of the EU4+UK markets and understand how analogous products had managed their entry and operational team. We helped them to explore and test various scenarios before a board-level decision to action entry to the EU. After this, we acted as the client’s local set-up partner, implementing launch plans and leading reimbursement, sales, and clinical support.